Ortho-McNeil Pharmaceutical
Ortho-McNeil Pharmaceutical
Ortho-McNeil Pharmaceutical was a pharmaceutical company that operated as a subsidiary of Johnson & Johnson. It was known for developing and marketing a range of prescription medications, particularly in the fields of neurology, psychiatry, and women's health.
History
Ortho-McNeil Pharmaceutical was formed through the merger of two companies: Ortho Pharmaceutical and McNeil Pharmaceutical. Ortho Pharmaceutical was originally founded in 1931 and was known for its contributions to the field of contraception and women's health. McNeil Pharmaceutical, on the other hand, was established in 1879 and became well-known for its development of Tylenol, a widely used analgesic.
The merger of these two companies allowed Ortho-McNeil to leverage the strengths of both entities, expanding its product offerings and research capabilities. The company became a significant player in the pharmaceutical industry, particularly in the United States.
Products
Ortho-McNeil Pharmaceutical developed and marketed a variety of prescription medications. Some of the notable products included:
- Topamax (topiramate) - An anticonvulsant used to treat epilepsy and prevent migraine headaches.
- Levaquin (levofloxacin) - An antibiotic used to treat a variety of bacterial infections.
- Ortho Tri-Cyclen - An oral contraceptive used for birth control and to treat acne.
Research and Development
The company invested heavily in research and development to bring new and innovative treatments to market. Ortho-McNeil's R&D efforts were focused on areas such as central nervous system disorders, infectious diseases, and women's health.
Merger and Transition
In 2008, Ortho-McNeil Pharmaceutical was merged with Janssen Pharmaceutica, another subsidiary of Johnson & Johnson, to form Ortho-McNeil-Janssen Pharmaceuticals. This merger was part of a strategic move to consolidate Johnson & Johnson's pharmaceutical operations and streamline its product offerings.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
